| Ytd | 9.67% | |
| 1y | 50.21% |
| Open | 225.29 | Prev Close | 226.34 | Low | 221.70 | High | 226.12 | Mkt Cap | 52.42B |
| Vol | 4.14M | Avg Vol | 2.02M | EPS | 7.23 | P/E | 31.17 | Forward P/E | 16.01 |
| Beta | 0.52 | Short Ratio | 3.62 | Inst. Own | 91.07% | Dividend | 2.06 | Div Yield | 0.91 |
| Ex Div Date | 10-01 | Earning | 11-05 | 50-d Avg | 233.55 | 200-d Avg | 216.82 | 1yr Est | 270.94 |
Cardinal Health (NYSE: CAH) CEO Jason Hollar said the company's fiscal 2026 performance was supporte
Cardinal Health NYSE: CAH CEO Jason Hollar said the company expects fiscal 2027 to extend the broad
Cardinal Health NYSE: CAH CEO Jason Hollar said the company's fiscal 2026 performance was supported
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
Cardinal Health expects IRA pricing changes to pressure Pharma revenues while protecting profitabili
The latest trading day saw Cardinal Health (CAH) settling at $232.36, representing a -1.08% change f
Cardinal Health, Inc. (CAH) Presents at 2026 Global Healthcare Conference Transcript
Cardinal Health, Inc. (CAH) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Tran
AbbVie is profitable, growing, and paying a rising dividend. CRISPR is burning cash in pursuit of a
Cencora (COR) just combined a stronger fiscal third quarter, a higher full year adjusted EPS outlook
Cardinal Health, Inc. stock (ISIN US14149Y1082) ended the last completed trading day on the New York
Cardinal Health stock closed at USD 224.95 on the New York Stock Exchange on September 18, 2026, dow